PACS: Approach-Avoidance and Alcohol Challenge Study in PTSD

Sponsor
University of Texas at Austin (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06002633
Collaborator
(none)
200
1
2
57
3.5

Study Details

Study Description

Brief Summary

Individuals with posttraumatic stress disorder (PTSD) have greater prevalence of alcohol use disorders (AUDs), with this comorbidity associated with worse illness outcomes, yet there remains limited mechanistic understanding of how PTSD confers risk for AUD. Understanding risk factors that associate with and predict the development of AUDs in PTSD could inform interventions and prevention efforts to reduce the rate of this comorbidity and improve outcomes of both disorders. Identifying predictors of risk requires longitudinal studies in PTSD aimed at capturing the mechanisms leading to the emergence of AUDs. There is growing evidence PTSD is related to biased decision-making during approach-avoidance conflict. Alcohol is also suggested to alter approach-avoidance decision-making. AUDs and acute alcohol intoxication is associated with a bias to seek out reward despite the possibility of threat (e.g., contributing to relapse following alcohol cue exposure and risky behavior during intoxication respectively). Alcohol-induced changes in approach-avoidance decision-making have not been investigated in the context of PTSD, but emerging data support the investigators' hypothesis that an interaction between alcohol and approach-avoidance conflict in PTSD may occur and contribute to risk for alcohol misuse and development of alcohol problems. No current data, cross-sectional or longitudinal, have tested the role of alcohol-induced changes in approach-avoidance conflict as a mechanism of risk for AUD among individuals with PTSD. To address this gap, the investigators propose to leverage the group's expertise in placebo-controlled alcohol administration procedures, longitudinal modeling, functional neuroimaging, and computational neuroscience approaches to investigate the effects of acute alcohol on approach-avoidance decision-making and mediating changes in multivariate neurocircuitry patterns in limbic, striatal, and salience networks.

Condition or Disease Intervention/Treatment Phase
  • Other: Alcohol
  • Other: Placebo
N/A

Detailed Description

The proposed study will test the conceptual model positing that acute alcohol alters the relative bias in computational mechanisms for threat vs reward, thereby decreasing avoidance to threat and increasing approach to reward in adults with PTSD, and through this mechanism increases risk for heavier alcohol use over time. Research aims are to identify alcohol-induced changes in approach-avoidance decision-making and mediating neural networks that predict alcohol use and symptoms of AUDs over a one-year follow-up period in adults with PTSD, compared to adults with interpersonal violence exposure but no PTSD and healthy comparison adults. Essential to successfully improving clinical prognosis in PTSD are research results that enable better prediction, diagnosis, and treatment based on the individual. There is a paucity of human clinical research investigating interactions between acute alcohol exposure and PTSD that may drive risk for development of AUDs following trauma. Data could identify brain and behavioral mechanisms explaining how alcohol alters an important domain of PTSD contributing to risk for alcohol misuse and development of alcohol problems. Results could pave way for development of novel behavioral and pharmacological methods to treat PTSD and decrease risk for developing comorbid AUDs.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Alcohol, Approach-Avoidance, and Neurocircuitry Interactions in PTSD
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
May 31, 2028
Anticipated Study Completion Date :
May 31, 2028

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Alcohol

Participants will drink beverages containing alcohol.

Other: Alcohol
Participants will consume beverages containing alcohol.

Placebo Comparator: Placebo

Participants will drink beverages containing a very low dose of alcohol (placebo condition).

Other: Placebo
Participants will consume beverages containing a very low dose of alcohol (placebo condition).

Outcome Measures

Primary Outcome Measures

  1. ratio of approach to avoidance choices [1 week]

    the number of trials on which individuals chose to avoid vs approach will be quantified during the task and compared between placebo and alcohol conditions

  2. changes in dorsal anterior cingulate cortex activation [1 week]

    the degree of activation on high conflict trials (relative to low conflict trials) on the task in the dorsal anterior cingulate will be quantified and compared between the placebo and alcohol conditions

  3. Relations between ratio of approach to avoidance choices with alcohol use over a one-year follow-up [1 year]

    The relationship between the number of trials on which individuals chose to avoid vs approach during the alcohol session with alcohol use over a one-year follow up will be modeled. Number of drinks consumed per day over the course of the follow-up year will be used to calculate Area Under the Curve (AUC), with AUC as the dependent variable.

  4. Relations between changes in dorsal anterior cingulate cortex activation with alcohol use over a one-year follow-up [1 year]

    The relationship between the degree of activation on high conflict trials (relative to low conflict trials) on the task in the dorsal anterior cingulate during the alcohol session with alcohol use over a one-year follow up will be modeled. Number of drinks consumed per day over the course of the follow-up year will be used to calculate Area Under the Curve (AUC), with AUC as the dependent variable.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
  1. Inclusion criteria for all participants:
  • between 21 and 60 years of age

  • having consumed at least 4 (men) or 3 (women) drinks on at least two occasions over the last year

  1. Inclusion criteria for PTSD participants:
  • Meeting diagnostic criteria for PTSD, confirmed by structured interview
  1. For all subjects exclusion criteria include:
  • history of significant medical illness, particularly if possible changes in cerebral tissue

  • neurologic abnormality including significant head trauma (loss of consciousness of ≥5-min)

  • full Scale IQ <85

  • contraindication to MRI scanning

  • positive pregnancy test

  • current alcohol or substance use disorder

  • scores > 15 on the alcohol Use Disorders Identification Test (AUDIT; part of phone screen)

  • ever being in an abstinence-oriented treatment program for alcohol use

  • reporting wanting to quit drinking but not being able to

  • any medical, religious, or other reasons for not drinking alcohol

  • history of heart attack, heart trouble, high blood pressure, diabetes, or liver disease

  • an adverse reaction to alcoholic beverages

  • reporting never consuming 4 (men) or 3 (women) or more drinks on at least two occasions over the last year

  • unwillingness to have a friend or family member drive them home after the alcohol administration sessions

  1. Additional exclusion criteria for participants in PTSD and IPV-exposed but no PTSD groups:
  • not taking medications for >4 weeks (i.e. participants must be stable on meds)

  • acute suicidality with intent

  • history of bipolar/psychotic disorder or OCD

  1. Additional exclusion criteria for participants in IPV-exposure but no PTSD group:
  • history of PTSD, current mental health disorders
  1. Additional exclusion criteria for healthy comparison subjects also include:
  • any prior psychiatric hospitalizations

  • lifetime history of a neurodevelopmental disorder, affective disorder, psychotic disorder, suicide attempt, or eating disorder

  • greater than 1 month of lifetime psychotropic medication

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Texas at Austin Austin Texas United States 78712

Sponsors and Collaborators

  • University of Texas at Austin

Investigators

  • Principal Investigator: Elizabeth Lippard, PhD, University of Texas at Austin
  • Principal Investigator: Josh Cisler, PhD, University of Texas at Austin

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Elizabeth Thomas Cox Lippard, Assistant Professor, University of Texas at Austin
ClinicalTrials.gov Identifier:
NCT06002633
Other Study ID Numbers:
  • R01AA030740
First Posted:
Aug 21, 2023
Last Update Posted:
Aug 21, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 21, 2023